Kura Oncology Inc (NASDAQ:KURA) has a beta value of 0.85 and has seen 0.85 million shares traded in the last trading session. The company, currently valued at $1.60B, closed the last trade at $21.04 per share which meant it lost -$1.3 on the day or -5.82% during that session. The KURA stock price is -14.88% off its 52-week high price of $24.17 and 64.78% above the 52-week low of $7.41. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.36 million shares traded. The 3-month trading volume is 1.51 million shares.
Kura Oncology Inc (NASDAQ:KURA) trade information
Sporting -5.82% in the red in last session, the stock has traded in the red over the last five days, when the KURA stock price touched $21.04 or saw a rise of 8.6%. Year-to-date, Kura Oncology Inc shares have moved 46.31%, while the 5-day performance has seen it change -7.80%. Over the past 30 days, the shares of Kura Oncology Inc (NASDAQ:KURA) have changed 2.58%. Short interest in the company has seen 11.02 million shares shorted with days to cover at 7.71.
Kura Oncology Inc (KURA) estimates and forecasts
Figures show that Kura Oncology Inc shares have underperformed across the wider relevant industry. The company’s shares have gained 112.74% over the past 6 months, with this year growth rate of -12.98%, compared to 13.60% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are -10.00% and -5.70% for the next quarter.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -3.94% over the past 5 years. Earnings growth for 2024 is a modest -10.26% while over the next 5 years, the company’s earnings are expected to increase by 19.93%.
KURA Dividends
Kura Oncology Inc is expected to release its next earnings report between May 08 and May 13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Kura Oncology Inc (NASDAQ:KURA)’s Major holders
Insiders own 1.75% of the company shares, while shares held by institutions stand at 105.54% with a share float percentage of 107.42%. Investors are also buoyed by the number of investors in a company, with Kura Oncology Inc having a total of 211 institutions that hold shares in the company. The top two institutional holders are Suvretta Capital Management, LLC with over 7.03 million shares worth more than $74.36 million. As of Jun 29, 2023, Suvretta Capital Management, LLC held 9.47% of shares outstanding.
The other major institutional holder is BVF Inc., with the holding of over 6.73 million shares as of Jun 29, 2023. The firm’s total holdings are worth over $71.21 million and represent 9.07% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF. As of Jun 29, 2023, the former fund manager holds about 2.96% shares in the company for having 2.2 million shares of worth $23.23 million while later fund manager owns 1.67 million shares of worth $16.54 million as of Aug 30, 2023, which makes it owner of about 2.24% of company’s outstanding stock.
